John Seger, MD
See Publications

Texas Heart Institute Positions

  • Teaching Staff, Cardiovascular Disease Fellowship
  • Teaching Staff, Clinical Cardiac Electrophysiology Fellowship

Interests

  • Cardiology
  • Echocardiology

Education

  • Undergraduate:

    Southern Methodist University

  • Medical School:

    The University of Texas-Houston Medical School

  • Residency:

    Baylor College of Medicine

  • Fellowships:

    The Texas Heart Institute

Academic & Clinical Affiliations

  • Baylor St. Luke's Medical Center
  • Houston Electrophysiology Associates

Honors, Awards and Memberships

Publications

4862227 DJYFUK6T 1 alternatives-to-animal-experimentation 10 date desc Seger 2088 https://www.texasheart.org/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%2277U2UHFA%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Gao%20et%20al.%22%2C%22parsedDate%22%3A%222023-04-29%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BGao%2C%20F.%2C%20Kherallah%2C%20R.%2C%20Koetting%2C%20M.%20et%20al.%20%282023%29.%20Leadless%20pacemaker%20with%20transcatheter%20aortic%20valve%20implantation%3A%20A%20single-center%20experience.%20%26lt%3Bi%26gt%3BPacing%20Clin%20Electrophysiol%26lt%3B%5C%2Fi%26gt%3B.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1111%5C%2Fpace.14702%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1111%5C%2Fpace.14702%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Leadless%20pacemaker%20with%20transcatheter%20aortic%20valve%20implantation%3A%20A%20single-center%20experience%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Feng%22%2C%22lastName%22%3A%22Gao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Riyad%22%2C%22lastName%22%3A%22Kherallah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mackenzie%22%2C%22lastName%22%3A%22Koetting%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leo%22%2C%22lastName%22%3A%22Simpson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%22%2C%22lastName%22%3A%22Seger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Srikanth%22%2C%22lastName%22%3A%22Koneru%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joseph%22%2C%22lastName%22%3A%22Coselli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ourania%22%2C%22lastName%22%3A%22Preventza%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vicente%22%2C%22lastName%22%3A%22Orozco-Sevilla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nastasya%22%2C%22lastName%22%3A%22Manon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guilherme%20V.%22%2C%22lastName%22%3A%22Silva%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20The%20safety%20and%20efficacy%20of%20leadless%20pacemakers%20%28LP%29%20in%20transcatheter%20aortic%20valve%20implant%20%28TAVI%29%20patients%20is%20not%20well%20known%20due%20to%20paucity%20of%20data.%20Herein%2C%20we%20compared%20outcomes%20between%20leadless%20pacemakers%20to%20traditional%20dual%20chamber%20pacemakers%20%28DCP%29%20following%20TAVI.%5CnMETHODS%3A%20A%20single-center%20retrospective%20study%20was%20conducted%2C%20including%20a%20total%20of%2027%20patients%20with%20LP%20and%2033%20patients%20with%20DCP%20after%20TAVI%20between%20November%202013%20and%20May%202021.%20We%20compared%20baseline%20demographics%2C%20pacemaker%20indications%2C%20complication%20rates%2C%20percent%20pacing%2C%20and%20ejection%20fractions.%5CnRESULTS%3A%20Leading%20indications%20for%20pacemaker%20implant%20were%20complete%20heart%20block%20%2874%25%20LP%2C%2073%25%20DCP%29%20and%20high%20degree%20atrioventricular%20block%20%2826%25%20LP%2C%2021%25%20DCP%29.%20Twenty-two%20%2882%25%29%20LP%20patients%20had%20devices%20implanted%20in%20the%20right%20ventricular%20septal-apex.%20Three%20%289%25%29%20DCP%20patients%20required%20rehospitalization%20for%20pocket%20related%20complications.%20Zero%20pacemaker-related%20mortality%20was%20observed%20in%20both%20groups.%20Frequency%20of%20ventricular%20pacing%20and%20ejection%20fraction%20was%20similar%20between%20LP%20and%20DCP%20groups.%5CnCONCLUSION%3A%20From%20this%20single-center%20retrospective%20study%2C%20LP%20implant%20was%20feasible%20following%20TAVI%20and%20was%20found%20to%20have%20comparable%20performance%20to%20DCPs.%20LPs%20may%20be%20a%20reasonable%20alternative%20in%20TAVI%20patients%20where%20single%20ventricular%20pacing%20is%20indicated.%20Larger%20studies%20are%20required%20to%20validate%20these%20findings.%22%2C%22date%22%3A%222023-04-29%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1111%5C%2Fpace.14702%22%2C%22ISSN%22%3A%221540-8159%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22SQD2CTYV%22%2C%22BJSZ96GT%22%2C%22DJYFUK6T%22%2C%22AAQ89W3S%22%2C%222K4N54U2%22%2C%22KRWEJ8EU%22%2C%22MZXU6P62%22%2C%22NTAHPDUG%22%2C%22FKNSPK49%22%5D%2C%22dateModified%22%3A%222023-07-21T18%3A44%3A29Z%22%7D%7D%2C%7B%22key%22%3A%22X6N4GYZG%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Kherallah%20et%20al.%22%2C%22parsedDate%22%3A%222020-06-20%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BKherallah%2C%20R.%20Y.%2C%20Harrison%2C%20D.%2C%20Lam%2C%20W.%20W.%20et%20al.%20%282020%29.%20Resolution%20of%20hypoxia%20and%20ascites%20with%20percutaneous%20intervention%20of%20Mustard%20baffle%20obstruction%20and%20leak.%20%26lt%3Bi%26gt%3BJACC%20Case%20Rep%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B2%26lt%3B%5C%2Fi%26gt%3B%2C%201079%26%23x2013%3B1083.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jaccas.2020.05.004%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jaccas.2020.05.004%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Resolution%20of%20hypoxia%20and%20ascites%20with%20percutaneous%20intervention%20of%20Mustard%20baffle%20obstruction%20and%20leak%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Riyad%20Y.%22%2C%22lastName%22%3A%22Kherallah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Darren%22%2C%22lastName%22%3A%22Harrison%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wilson%20W.%22%2C%22lastName%22%3A%22Lam%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Srinath%22%2C%22lastName%22%3A%22Gowda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20J.%22%2C%22lastName%22%3A%22Seger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20R.%22%2C%22lastName%22%3A%22Ermis%22%7D%5D%2C%22abstractNote%22%3A%22A%2045-year-old%20man%20with%20history%20of%20Mustard%20repair%20for%20transposition%20of%20the%20great%20arteries%2C%20cirrhosis%2C%20and%20chronic%20hypoxemic%20respiratory%20failure%20presented%20for%20subacute%20worsening%20of%20his%20chronic%20symptoms%2C%20which%20were%20found%20to%20be%20secondary%20to%20a%20previously%20unrecognized%20baffle%20stenosis%20and%20leak.%20Percutaneous%20intervention%20resolved%20his%20ascites%20and%20hypoxia.%20%28Level%5Cu00a0of%5Cu00a0Difficulty%3A%20Intermediate.%29.%22%2C%22date%22%3A%22Jun%2020%202020%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jaccas.2020.05.004%22%2C%22ISSN%22%3A%222666-0849%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22DJYFUK6T%22%2C%225P97GH9U%22%2C%22QNJADXH4%22%5D%2C%22dateModified%22%3A%222021-08-05T19%3A58%3A32Z%22%7D%7D%2C%7B%22key%22%3A%22QHVFQMAG%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Knight%20et%20al.%22%2C%22parsedDate%22%3A%222019-03%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BKnight%2C%20B.%20P.%2C%20Novak%2C%20P.%20G.%2C%20Sangrigoli%2C%20R.%20et%20al.%20%282019%29.%20Long-Term%20Outcomes%20After%20Ablation%20for%20Paroxysmal%20Atrial%20Fibrillation%20Using%20the%20Second-Generation%20Cryoballoon%3A%20Final%20Results%20From%20STOP%20AF%20Post-Approval%20Study.%20%26lt%3Bi%26gt%3BJACC%20Clin%20Electrophysiol%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B5%26lt%3B%5C%2Fi%26gt%3B%2C%20306%26%23x2013%3B314.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jacep.2018.11.006%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jacep.2018.11.006%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Long-Term%20Outcomes%20After%20Ablation%20for%20Paroxysmal%20Atrial%20Fibrillation%20Using%20the%20Second-Generation%20Cryoballoon%3A%20Final%20Results%20From%20STOP%20AF%20Post-Approval%20Study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bradley%20P.%22%2C%22lastName%22%3A%22Knight%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paul%20G.%22%2C%22lastName%22%3A%22Novak%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%22%2C%22lastName%22%3A%22Sangrigoli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean%22%2C%22lastName%22%3A%22Champagne%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marc%22%2C%22lastName%22%3A%22Dubuc%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stuart%20W.%22%2C%22lastName%22%3A%22Adler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20Thomas%22%2C%22lastName%22%3A%22Svinarich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vidal%22%2C%22lastName%22%3A%22Essebag%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%22%2C%22lastName%22%3A%22Hokanson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fred%22%2C%22lastName%22%3A%22Kueffer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandeep%20K.%22%2C%22lastName%22%3A%22Jain%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Roy%20M.%22%2C%22lastName%22%3A%22John%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Moussa%22%2C%22lastName%22%3A%22Mansour%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22STOP%20AF%20PAS%20Investigators%22%7D%5D%2C%22abstractNote%22%3A%22OBJECTIVES%3A%20STOP%20AF%20PAS%20%28Sustained%20Treatment%20of%20Paroxysmal%20Atrial%20Fibrillation%20Post-Approval%20Study%29%20is%20the%20first%20prospective%2C%20multicenter%2C%203-year%20study%20in%20North%20America%20to%20assess%20long-term%20safety%20and%20effectiveness%20of%20the%20cryoballoon%20for%20treatment%20of%20patients%20with%20drug-refractory%20symptomatic%20pAF.%5CnBACKGROUND%3A%20The%20STOP%20AF%20PAS%20was%20required%20by%20the%20U.S.%20Food%20and%20Drug%20Administration%20at%20the%20time%20of%20approval%20of%20the%20first-generation%20cryoballoon%20for%20the%20treatment%20of%20paroxysmal%20atrial%20fibrillation%20%28pAF%29.%20The%20second-generation%20cryoballoon%20%28CB2%29%20was%20commercially%20released%20shortly%20after%20this%20trial%20was%20initiated.%5CnMETHODS%3A%20The%20study%20was%20nonrandomized.%20Enrollment%20was%20completed%20with%20344%20eligible%20patients%20undergoing%20pulmonary%20vein%20isolation%20%28PVI%29%20using%20the%20CB2.%20Procedure-related%20safety%20and%20freedom%20from%20AF%20and%20symptomatic%20atrial%20flutter%5C%2Fatrial%20tachycardia%20through%203%20years%20were%20determined.%20Documented%20atrial%20arrhythmias%5Cu00a0%5Cu226530%20s%20were%20considered%20treatment%20failures.%5CnRESULTS%3A%20Acute%20PVI%20was%20achieved%20in%2099.3%25%20%281%2C341%20of%201%2C350%29%20of%20veins.%20Mean%20follow-up%20was%2034%20%5Cu00b1%207%20months.%20The%20rate%20of%20major%20complications%20was%205.8%25%2C%20including%20a%203.2%25%20rate%20of%20phrenic%20nerve%20injury%2C%20which%20resolved%20in%20all%20but%201%20patient%20by%2036%20months.%20At%2036%20months%2C%2011.7%25%20of%20patients%20were%20prescribed%20antiarrhythmic%20agents%2C%20inclusive%20of%20%26quot%3Bpill-in-the-pocket%26quot%3B%20administration.%20Freedom%20from%20AF%20was%2081.6%25%20at%2012%20months%2C%2073.8%25%20at%2024%20months%2C%20and%2068.1%25%20at%2036%20months.%20Freedom%20from%20AF%20and%20symptomatic%20atrial%20flutter%5C%2Fatrial%20tachycardia%20was%2079.0%25%20at%2012%20months%2C%2070.8%25%20at%2024%20months%2C%20and%2064.1%25%20at%2036%20months.%20Freedom%20from%20a%20repeat%20ablation%20procedure%20was%2080.9%25%20at%2036%20months.%5CnCONCLUSIONS%3A%20PVI%20using%20the%20CB2%20was%20an%20effective%20treatment%20for%20patients%20with%20pAF%2C%20with%20freedom%20from%20all%20atrial%20arrhythmias%20of%2064%25%20at%2036%20months.%20%28Sustained%20Treatment%20of%20Paroxysmal%20Atrial%20Fibrillation%20Post-Approval%20Study%20%5BSTOP%5Cu00a0AF%5Cu00a0PAS%5D%3B%20NCT01456949%29.%22%2C%22date%22%3A%22Mar%202019%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jacep.2018.11.006%22%2C%22ISSN%22%3A%222405-5018%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22DJYFUK6T%22%5D%2C%22dateModified%22%3A%222019-04-11T15%3A20%3A11Z%22%7D%7D%2C%7B%22key%22%3A%22EEXJRKYW%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Su%20et%20al.%22%2C%22parsedDate%22%3A%222018-04%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BSu%2C%20W.%2C%20Orme%2C%20G.%20J.%2C%20Hoyt%2C%20R.%20et%20al.%20%282018%29.%20Retrospective%20review%20of%20arctic%20front%20advance%20cryoballoon%20ablation%3A%20a%20multicenter%20examination%20of%20second-generation%20cryoballoon%20%28RADICOOL%20trial%29.%20%26lt%3Bi%26gt%3BJ%20Interv%20Card%20Electrophysiol%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B51%26lt%3B%5C%2Fi%26gt%3B%2C%20199%26%23x2013%3B204.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs10840-018-0335-1%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs10840-018-0335-1%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Retrospective%20review%20of%20arctic%20front%20advance%20cryoballoon%20ablation%3A%20a%20multicenter%20examination%20of%20second-generation%20cryoballoon%20%28RADICOOL%20trial%29%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wilber%22%2C%22lastName%22%3A%22Su%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22G.%20Joseph%22%2C%22lastName%22%3A%22Orme%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%22%2C%22lastName%22%3A%22Hoyt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%22%2C%22lastName%22%3A%22Baker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Steven%22%2C%22lastName%22%3A%22Compton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%22%2C%22lastName%22%3A%22Fellows%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%22%2C%22lastName%22%3A%22Harding%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20Thomas%22%2C%22lastName%22%3A%22Svinarich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcin%22%2C%22lastName%22%3A%22Kowalski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bryan%22%2C%22lastName%22%3A%22Piedad%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Kenigsberg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%22%2C%22lastName%22%3A%22Seger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zeshan%20K.%22%2C%22lastName%22%3A%22Ahmad%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paul%22%2C%22lastName%22%3A%22Wang%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Pulmonary%20vein%20isolation%20%28PVI%29%20via%20catheter%20ablation%20is%20an%20approved%20therapy%20for%20patients%20with%20drug-refractory%20and%20symptomatic%20atrial%20fibrillation%20%28AF%29.%20Furthermore%2C%20cryoballoon%20is%20now%20considered%20to%20be%20as%20effective%20as%20focal%20radiofrequency%20catheter%20ablation.%20This%20study%20examines%20the%20second-generation%20cryoballoon%20performance%20in%20a%20US%20multicenter%20review%20of%20real-world%20practices.%5CnMETHODS%3A%20By%20retrospective%20chart%20collections%2C%20the%20long-term%20efficacy%20and%20safety%20of%20the%20cryoballoon%20procedure%20were%20assessed%20in%2015%20US%20centers.%20All%20patients%20had%20a%20history%20of%20drug-refractory%20symptomatic%20paroxysmal%20AF%20and%20were%20treated%20with%20a%20cryoballoon%20PVI%20strategy%20at%20the%20index%20ablation.%5CnRESULTS%3A%20Four%20hundred%20fifty-two%20patients%20were%20evaluated%2C%20and%20acute%20PVI%20was%20achieved%20in%2099%25%20of%20patients%20by%20cryoballoon%20catheter%20ablation.%20In%200.88%25%20of%20patients%20%284%5C%2F452%29%2C%20an%20additional%20focal%20ablation%20catheter%20was%20used%20to%20achieve%20acute%20PVI%20during%20the%20ablation%20procedure.%20Average%20procedure%20time%20was%20128%20%28range%2082%20to%20260%29%5Cu00a0min%2C%20using%20an%20average%20of%2017%20%28range%201%20to%2019%29%5Cu00a0min%20of%20fluoroscopy.%20The%20most%20frequent%20adverse%20event%20was%20transient%20phrenic%20nerve%20injury%20%281.5%25%3B%207%5C%2F452%20patients%29%20which%20all%20resolved%20by%20the%20end%20of%20the%20procedure%20with%20no%20diaphragmatic%20dysfunction%20at%20discharge.%20There%20were%20no%20strokes%2C%20transient%20ischemic%20attacks%2C%20cardiac%20tamponade%2C%20atrioesophageal%20fistulas%2C%20or%20deaths%20during%20the%20study.%20At%20the%2012-month%20efficacy%20endpoint%2C%20single-procedure%20success%20of%20freedom%20from%20atrial%20arrhythmia%20was%2087%25%20%28393%5C%2F452%20patients%29.%5CnCONCLUSIONS%3A%20This%20real-world%20examination%20of%20the%20US%20practice%20demonstrates%20that%20second-generation%20cryoballoon%20ablation%20by%20PVI%20strategy%20is%20safe%20and%20effective%20among%20patients%20with%20paroxysmal%20AF.%22%2C%22date%22%3A%22Apr%202018%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1007%5C%2Fs10840-018-0335-1%22%2C%22ISSN%22%3A%221572-8595%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22DJYFUK6T%22%5D%2C%22dateModified%22%3A%222018-05-08T17%3A42%3A26Z%22%7D%7D%2C%7B%22key%22%3A%22X8MVDFSR%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Reynolds%20et%20al.%22%2C%22parsedDate%22%3A%222016-02-11%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BReynolds%2C%20D.%2C%20Duray%2C%20G.%20Z.%2C%20Omar%2C%20R.%20et%20al.%20%282016%29.%20A%20leadless%20intracardiac%20transcatheter%20pacing%20system.%20%26lt%3Bi%26gt%3BN%20Engl%20J%20Med%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B374%26lt%3B%5C%2Fi%26gt%3B%2C%20533%26%23x2013%3B541.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1056%5C%2FNEJMoa1511643%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1056%5C%2FNEJMoa1511643%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20leadless%20intracardiac%20transcatheter%20pacing%20system%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dwight%22%2C%22lastName%22%3A%22Reynolds%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gabor%20Z.%22%2C%22lastName%22%3A%22Duray%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Razali%22%2C%22lastName%22%3A%22Omar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kyoko%22%2C%22lastName%22%3A%22Soejima%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Petr%22%2C%22lastName%22%3A%22Neuzil%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shu%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Calambur%22%2C%22lastName%22%3A%22Narasimhan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clemens%22%2C%22lastName%22%3A%22Steinwender%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Josep%22%2C%22lastName%22%3A%22Brugada%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Lloyd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paul%20R.%22%2C%22lastName%22%3A%22Roberts%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Venkata%22%2C%22lastName%22%3A%22Sagi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%22%2C%22lastName%22%3A%22Hummel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maria%20Grazia%22%2C%22lastName%22%3A%22Bongiorni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Reinoud%20E.%22%2C%22lastName%22%3A%22Knops%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%20R.%22%2C%22lastName%22%3A%22Ellis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charles%20C.%22%2C%22lastName%22%3A%22Gornick%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%20A.%22%2C%22lastName%22%3A%22Bernabei%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Verla%22%2C%22lastName%22%3A%22Laager%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kurt%22%2C%22lastName%22%3A%22Stromberg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eric%20R.%22%2C%22lastName%22%3A%22Williams%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20Harrison%22%2C%22lastName%22%3A%22Hudnall%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Philippe%22%2C%22lastName%22%3A%22Ritter%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Micra%20Transcatheter%20Pacing%20Study%20Group%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20A%20leadless%20intracardiac%20transcatheter%20pacing%20system%20has%20been%20designed%20to%20avoid%20the%20need%20for%20a%20pacemaker%20pocket%20and%20transvenous%20lead.%5CnMETHODS%3A%20In%20a%20prospective%20multicenter%20study%20without%20controls%2C%20a%20transcatheter%20pacemaker%20was%20implanted%20in%20patients%20who%20had%20guideline-based%20indications%20for%20ventricular%20pacing.%20The%20analysis%20of%20the%20primary%20end%20points%20began%20when%20300%20patients%20reached%206%20months%20of%20follow-up.%20The%20primary%20safety%20end%20point%20was%20freedom%20from%20system-related%20or%20procedure-related%20major%20complications.%20The%20primary%20efficacy%20end%20point%20was%20the%20percentage%20of%20patients%20with%20low%20and%20stable%20pacing%20capture%20thresholds%20at%206%20months%20%28%5Cu22642.0%20V%20at%20a%20pulse%20width%20of%200.24%20msec%20and%20an%20increase%20of%20%5Cu22641.5%20V%20from%20the%20time%20of%20implantation%29.%20The%20safety%20and%20efficacy%20end%20points%20were%20evaluated%20against%20performance%20goals%20%28based%20on%20historical%20data%29%20of%2083%25%20and%2080%25%2C%20respectively.%20We%20also%20performed%20a%20post%20hoc%20analysis%20in%20which%20the%20rates%20of%20major%20complications%20were%20compared%20with%20those%20in%20a%20control%20cohort%20of%202667%20patients%20with%20transvenous%20pacemakers%20from%20six%20previously%20published%20studies.%5CnRESULTS%3A%20The%20device%20was%20successfully%20implanted%20in%20719%20of%20725%20patients%20%2899.2%25%29.%20The%20Kaplan-Meier%20estimate%20of%20the%20rate%20of%20the%20primary%20safety%20end%20point%20was%2096.0%25%20%2895%25%20confidence%20interval%20%5BCI%5D%2C%2093.9%20to%2097.3%3B%20P%26lt%3B0.001%20for%20the%20comparison%20with%20the%20safety%20performance%20goal%20of%2083%25%29%3B%20there%20were%2028%20major%20complications%20in%2025%20of%20725%20patients%2C%20and%20no%20dislodgements.%20The%20rate%20of%20the%20primary%20efficacy%20end%20point%20was%2098.3%25%20%2895%25%20CI%2C%2096.1%20to%2099.5%3B%20P%26lt%3B0.001%20for%20the%20comparison%20with%20the%20efficacy%20performance%20goal%20of%2080%25%29%20among%20292%20of%20297%20patients%20with%20paired%206-month%20data.%20Although%20there%20were%2028%20major%20complications%20in%2025%20patients%2C%20patients%20with%20transcatheter%20pacemakers%20had%20significantly%20fewer%20major%20complications%20than%20did%20the%20control%20patients%20%28hazard%20ratio%2C%200.49%3B%2095%25%20CI%2C%200.33%20to%200.75%3B%20P%3D0.001%29.%5CnCONCLUSIONS%3A%20In%20this%20historical%20comparison%20study%2C%20the%20transcatheter%20pacemaker%20met%20the%20prespecified%20safety%20and%20efficacy%20goals%3B%20it%20had%20a%20safety%20profile%20similar%20to%20that%20of%20a%20transvenous%20system%20while%20providing%20low%20and%20stable%20pacing%20thresholds.%20%28Funded%20by%20Medtronic%3B%20Micra%20Transcatheter%20Pacing%20Study%20ClinicalTrials.gov%20number%2C%20NCT02004873.%29.%22%2C%22date%22%3A%22Feb%2011%2C%202016%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1056%5C%2FNEJMoa1511643%22%2C%22ISSN%22%3A%221533-4406%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22DJYFUK6T%22%5D%2C%22dateModified%22%3A%222018-05-04T20%3A57%3A47Z%22%7D%7D%2C%7B%22key%22%3A%22LV2A6A62%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Lam%20et%20al.%22%2C%22parsedDate%22%3A%222015-08%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BLam%2C%20W.%20W.%2C%20Reyes%2C%20M.%20A.%20and%20%26lt%3Bstrong%26gt%3BSeger%26lt%3B%5C%2Fstrong%26gt%3B%2C%20J.%20J.%20%282015%29.%20Plasma%20exchange%20for%20urgent%20apixaban%20reversal%20in%20a%20case%20of%20hemorrhagic%20tamponade%20after%20pacemaker%20implantation.%20%26lt%3Bi%26gt%3BTex%20Heart%20Inst%20J%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B42%26lt%3B%5C%2Fi%26gt%3B%2C%20377%26%23x2013%3B380.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.14503%5C%2FTHIJ-14-4424%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.14503%5C%2FTHIJ-14-4424%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Plasma%20exchange%20for%20urgent%20apixaban%20reversal%20in%20a%20case%20of%20hemorrhagic%20tamponade%20after%20pacemaker%20implantation%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wilson%20W.%22%2C%22lastName%22%3A%22Lam%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Meredith%20A.%22%2C%22lastName%22%3A%22Reyes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20J.%22%2C%22lastName%22%3A%22Seger%22%7D%5D%2C%22abstractNote%22%3A%22We%20report%20the%20case%20of%20an%2082-year-old%20man%20in%20whom%20hemorrhagic%20pericardial%20effusion%20occurred%20one%20week%20after%20pacemaker%20implantation%2C%20while%20he%20was%20taking%20apixaban.%20Few%20therapies%20exist%20for%20reversing%20the%20anti-Xa%20effect%20of%20apixaban.%20To%20reverse%20anticoagulation%2C%20our%20patient%20underwent%20plasma%20exchange%2C%20which%20facilitated%20pericardiocentesis%20and%20prevented%20possible%20surgical%20intervention.%20To%20our%20knowledge%2C%20this%20is%20the%20first%20report%20of%20the%20use%20of%20plasmapheresis%20to%20reverse%20the%20anticoagulant%20effect%20of%20apixaban.%22%2C%22date%22%3A%22Aug%202015%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.14503%5C%2FTHIJ-14-4424%22%2C%22ISSN%22%3A%221526-6702%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22DJYFUK6T%22%2C%225P97GH9U%22%5D%2C%22dateModified%22%3A%222018-05-08T17%3A44%3A25Z%22%7D%7D%2C%7B%22key%22%3A%22HQZ7944C%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Vasquez%20and%20Seger%22%2C%22parsedDate%22%3A%222009-11%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BVasquez%2C%20A.%20F.%20and%20%26lt%3Bstrong%26gt%3BSeger%26lt%3B%5C%2Fstrong%26gt%3B%2C%20J.%20J.%20%282009%29.%20An%20uncommon%20case%20of%20heart%20failure.%20%26lt%3Bi%26gt%3BSouth%20Med%20J%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B102%26lt%3B%5C%2Fi%26gt%3B%2C%201183%26%23x2013%3B1185.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FSMJ.0b013e3181b63b1c%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FSMJ.0b013e3181b63b1c%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22An%20uncommon%20case%20of%20heart%20failure%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andres%20F.%22%2C%22lastName%22%3A%22Vasquez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20J.%22%2C%22lastName%22%3A%22Seger%22%7D%5D%2C%22abstractNote%22%3A%22A%2055-year-old%20man%20evaluated%20for%20syncope%20had%20mild%20and%20gradually%20progressive%20left%20ventricular%20systolic%20dysfunction%20on%20initial%20workup.%20Although%20not%20identified%20initially%2C%20repeat%20cardiac%20magnetic%20resonance%20one%20year%20later%20demonstrated%20the%20presence%20of%20trabeculations%20in%20the%20left%20ventricle%20consistent%20with%20the%20diagnosis%20of%20isolated%20non-compaction%20of%20the%20left%20ventricular%20myocardium.%20This%20case%20highlights%20the%20need%20for%20increased%20awareness%20of%20this%20entity%20among%20primary%20care%20physicians%2C%20cardiologists%2C%20and%20radiologists%20in%20order%20to%20enhance%20its%20identification.%20This%20case%20also%20demonstrates%20the%20advantages%20of%20cardiac%20magnetic%20resonance%20for%20diagnosis%20and%20provides%20insight%20into%20this%20rare%20type%20of%20cardiomyopathy%20in%20adults.%22%2C%22date%22%3A%22Nov%202009%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1097%5C%2FSMJ.0b013e3181b63b1c%22%2C%22ISSN%22%3A%221541-8243%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22DJYFUK6T%22%5D%2C%22dateModified%22%3A%222018-05-02T17%3A50%3A27Z%22%7D%7D%2C%7B%22key%22%3A%22VMA4VPGQ%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Seger%22%2C%22parsedDate%22%3A%222005%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bstrong%26gt%3BSeger%26lt%3B%5C%2Fstrong%26gt%3B%2C%20J.%20J.%20%282005%29.%20Syncope%20evaluation%20and%20management.%20%26lt%3Bi%26gt%3BTex%20Heart%20Inst%20J%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B32%26lt%3B%5C%2Fi%26gt%3B%2C%20204%26%23x2013%3B206%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Syncope%20evaluation%20and%20management%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20J.%22%2C%22lastName%22%3A%22Seger%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222005%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%22%22%2C%22ISSN%22%3A%220730-2347%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22DJYFUK6T%22%5D%2C%22dateModified%22%3A%222022-02-17T16%3A10%3A17Z%22%7D%7D%2C%7B%22key%22%3A%22F7MIMBJQ%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Zhang%20et%20al.%22%2C%22parsedDate%22%3A%222004-04-06%22%2C%22numChildren%22%3A5%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BZhang%2C%20S.%2C%20Younis%2C%20G.%2C%20Hariharan%2C%20R.%20et%20al.%20%282004%29.%20Lower%20loop%20reentry%20as%20a%20mechanism%20of%20clockwise%20right%20atrial%20flutter.%20%26lt%3Bi%26gt%3BCirculation%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B109%26lt%3B%5C%2Fi%26gt%3B%2C%201630%26%23x2013%3B1635.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1161%5C%2F01.CIR.0000124221.84399.48%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1161%5C%2F01.CIR.0000124221.84399.48%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Lower%20loop%20reentry%20as%20a%20mechanism%20of%20clockwise%20right%20atrial%20flutter%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shulong%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22George%22%2C%22lastName%22%3A%22Younis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ramesh%22%2C%22lastName%22%3A%22Hariharan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%22%2C%22lastName%22%3A%22Ho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yanfei%22%2C%22lastName%22%3A%22Yang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%22%2C%22lastName%22%3A%22Ip%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ranjun%20K.%22%2C%22lastName%22%3A%22Thakur%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%22%2C%22lastName%22%3A%22Seger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Melvin%20M.%22%2C%22lastName%22%3A%22Scheinman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jie%22%2C%22lastName%22%3A%22Cheng%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Right%20atrial%20reentrant%20tachycardia%20resulting%20from%20lower%20loop%20reentry%20%28LLR%29%20around%20the%20inferior%20vena%20cava%20%28IVC%29%20has%20been%20described%20recently.%20However%2C%20all%20reported%20cases%20of%20LLR%20in%20the%20literature%20have%20negative%20flutter%20waves%20on%20the%20inferior%20surface%20ECG%20leads%20similar%20to%20that%20of%20counterclockwise%20typical%20atrial%20flutter%20around%20the%20tricuspid%20annulus%20%28TA%29.%20Right%20atrial%20flutter%20with%20positive%20flutter%20waves%20in%20the%20inferior%20ECG%20leads%20has%20been%20assumed%20to%20rotate%20as%20a%20single%20reentrant%20activation%20wave%20front%20around%20the%20TA%2C%20and%20the%20role%20of%20LLR%20in%20those%20patients%20is%20not%20known.%5CnMETHODS%20AND%20RESULTS%3A%20Twelve%20consecutive%20patients%20with%20flutter%20wave%20morphology%20on%20surface%20ECG%20consistent%20with%20clockwise%20atrial%20flutter%20were%20studied.%20The%20endocardial%20activation%20pattern%20recorded%20from%20conventional%20multipolar%20electrode%20catheters%20was%20characteristic%20of%20clockwise%20atrial%20flutter%20around%20the%20TA.%20Entrainment%20pacing%20in%20all%2012%20patients%20and%203D%20activation%20sequence%20mapping%20in%207%20patients%2C%20however%2C%20revealed%20clockwise%20LLR%20involving%20the%20lower%20right%20atrium%20around%20the%20IVC%20in%207%20patients%2C%20figure-of-8%20double-loop%20reentry%20around%20both%20the%20IVC%20and%20TA%20in%204%2C%20and%20single%20reentrant%20loop%20around%20the%20TA%20in%201.%20Linear%20radiofrequency%20ablation%20in%20the%20isthmus%20between%20the%20TA%20and%20IVC%20%28TI%20isthmus%29%20terminated%20the%20tachycardia%20in%20all%20patients.%5CnCONCLUSIONS%3A%20Surface%20ECG%20flutter%20wave%20morphology%20and%20limited%20recording%20intracardiac%20sites%20proved%20insufficient%20to%20delineate%20the%20precise%20mechanism%20of%20the%20TI%20isthmus-dependent%20clockwise%20right%20atrial%20flutters.%20Most%20right%20atrial%20flutters%20with%20positive%20flutter%20wave%20on%20surface%20ECG%20may%20be%20supported%20by%20a%20reentrant%20circuit%20around%20the%20IVC%20or%20a%20figure-of-8%20double-loop%20reentry%20involving%20both%20the%20IVC%20and%20TA.%22%2C%22date%22%3A%222004-04-06%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1161%5C%2F01.CIR.0000124221.84399.48%22%2C%22ISSN%22%3A%221524-4539%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%228EPJLFD3%22%2C%22DJYFUK6T%22%2C%22JZZF2YYQ%22%5D%2C%22dateModified%22%3A%222022-02-25T19%3A17%3A08Z%22%7D%7D%5D%7D
Gao, F., Kherallah, R., Koetting, M. et al. (2023). Leadless pacemaker with transcatheter aortic valve implantation: A single-center experience. Pacing Clin Electrophysiol. https://doi.org/10.1111/pace.14702.
Kherallah, R. Y., Harrison, D., Lam, W. W. et al. (2020). Resolution of hypoxia and ascites with percutaneous intervention of Mustard baffle obstruction and leak. JACC Case Rep 2, 1079–1083. https://doi.org/10.1016/j.jaccas.2020.05.004.
Knight, B. P., Novak, P. G., Sangrigoli, R. et al. (2019). Long-Term Outcomes After Ablation for Paroxysmal Atrial Fibrillation Using the Second-Generation Cryoballoon: Final Results From STOP AF Post-Approval Study. JACC Clin Electrophysiol 5, 306–314. https://doi.org/10.1016/j.jacep.2018.11.006.
Su, W., Orme, G. J., Hoyt, R. et al. (2018). Retrospective review of arctic front advance cryoballoon ablation: a multicenter examination of second-generation cryoballoon (RADICOOL trial). J Interv Card Electrophysiol 51, 199–204. https://doi.org/10.1007/s10840-018-0335-1.
Reynolds, D., Duray, G. Z., Omar, R. et al. (2016). A leadless intracardiac transcatheter pacing system. N Engl J Med 374, 533–541. https://doi.org/10.1056/NEJMoa1511643.
Lam, W. W., Reyes, M. A. and Seger, J. J. (2015). Plasma exchange for urgent apixaban reversal in a case of hemorrhagic tamponade after pacemaker implantation. Tex Heart Inst J 42, 377–380. https://doi.org/10.14503/THIJ-14-4424.
Vasquez, A. F. and Seger, J. J. (2009). An uncommon case of heart failure. South Med J 102, 1183–1185. https://doi.org/10.1097/SMJ.0b013e3181b63b1c.
Seger, J. J. (2005). Syncope evaluation and management. Tex Heart Inst J 32, 204–206
Zhang, S., Younis, G., Hariharan, R. et al. (2004). Lower loop reentry as a mechanism of clockwise right atrial flutter. Circulation 109, 1630–1635. https://doi.org/10.1161/01.CIR.0000124221.84399.48.